Endothelial Glycocalyx in Blood-Brain Barrier Integrity and Neurovascular Health"

The maintenance of the immune privileged environment within the central nervous system (CNS) is fundamentally dependent upon the blood-brain barrier (BBB), a sophisticated multicellular interface that precisely governs the exchange of solutes between the systemic circulation and the brain parenchyma. The structural paradigm of this barrier was centered almost exclusively on the cellular architecture of the neurovascular unit (NVU), with particular emphasis placed on the restrictive properties of paracellular tight junctions and the metabolic coupling between pericytes and astrocytes. However, recent breakthroughs in high resolution imaging and intravital microscopy have catalysed a fundamental shift in our understanding of this interface, revealing that the primary gatekeeper of the neurovasculature is a luminal, noncellular component known as the endothelial glycocalyx (eGC). This carbohydrate rich macromolecular meshwork, composed of proteoglycans and glycosaminoglycans, serves as the definitive physical and biochemical shield of the endothelium. By acting as the first line of defence against circulating inflammatory cells and hydrostatic forces, the endothelial glycocalyx transcends its role as a simple molecular sieve to function as a dynamic mechanotransducer that is essential for preserving the homeostatic sanctity of the brain. The eGC is a highly organized, carbohydrate-rich macromolecular matrix that coats the apical surface of brain microvascular endothelial cells. This "glycan landscape" is composed of a diverse array of proteoglycans (e.g., Syndecans, Glypicans, and the basement-membrane-associated Agrin) and glycosaminoglycans, primarily heparan sulfate and hyaluronan. Unlike peripheral vascular beds, the brain microvascular eGC is uniquely adapted to meet the metabolic and homeostatic rigors of the CNS, serving as a dynamic mechanotransducer that converts hemodynamic forces into biochemical signals vital for barrier stability. The integrity of the eGC is not merely a correlation of vascular health but a primary determinant of it. Pathological shedding of this layer driven by the enzymatic activation of heparanase and matrix metalloproteinases (MMPs) is now recognized as a "sentinel event" in the pathogenesis of acute CNS injuries. Recent studies demonstrate that systemic glycocalyx degradation mediates the transition from compensated vascular stress to overt hyperpermeability in traumatic brain injury and ischemic stroke. Furthermore, the scope of eGC research has expanded to include systemic influences, such as the gut-brain-vascular axis, and chronic neurodegenerative processes, where age-related dysregulation of the glycocalyx facilitates the cognitive decline associated with barrier failure.